Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-02-14
1995-02-21
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548235, 548236, C07D49318
Patent
active
053915640
ABSTRACT:
Rhizoxin and rhizoxin-2-ene derivatives of formula (I): ##STR1## in which: n is 1 to 25: A is an extra bond or oxygen, X is oxygen, sulfur, nitrogen or carbonyl; and R is hydrogen, carboxylic acyl having from 1 to 25 carbon atoms, alkoxycarbonyl group having from 2 to 26 carbon atoms, phosphono, alkylphosphono group in which the alkyl part has from 1 to 25 carbon atoms, dialkylphosphono group in which each alkyl part has from 1 to 25 carbon atoms, alkyl group having from 1 to 25 carbon atoms, aralkyl, cycloalkyl, heterocyclic, alkylthio group in which the alkyl part has from 1 to 25 carbon atoms, aralkylthio, or heterocyclylthio, or when X represents a nitrogen atom, R is R.sup.1 and R.sup.2, where R.sup.1 and R.sup.2 are hydrogen, alkyl, acyl, alkoxycarbonyl, phosphono, alkylphosphono or dialkylphosphono have valuable anti-tumor activity. They may be prepared by acylation of rhizoxin or rhizoxin-2-ene.
REFERENCES:
Burger, "Medicinal Chemistry 2d Ed.", Interscience, N.Y., 1960, p. 42.
Ueda et al., Chem. Abstr., vol. 113, entry 218230y abstracting Japan 02196789 (1990).
Kaneko et al., Chem. Abstr., vol. 113, entry 114948x abstracting Europe 350 315 (1990).
Kamokari Makoto
Kaneko Masakatsu
Kobayashi Tomowo
Sasagawa Kazuhiko
Daus Donald G.
Sankyo Company Limited
LandOfFree
Rhizoxin derivatives and their use as anti-tumor agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Rhizoxin derivatives and their use as anti-tumor agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Rhizoxin derivatives and their use as anti-tumor agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1929996